- Home
- MD vs RLAY Comparison
MD vs RLAY Comparison
Compare MD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MD
- RLAY
- Stock Information
- Founded
- MD 1979
- RLAY 2015
- Country
- MD United States
- RLAY United States
- Employees
- MD N/A
- RLAY N/A
- Industry
- MD Hospital/Nursing Management
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MD Health Care
- RLAY Health Care
- Exchange
- MD Nasdaq
- RLAY Nasdaq
- Market Cap
- MD 1.0B
- RLAY 1.1B
- IPO Year
- MD 1995
- RLAY 2020
- Fundamental
- Price
- MD $14.01
- RLAY $4.45
- Analyst Decision
- MD Buy
- RLAY Strong Buy
- Analyst Count
- MD 7
- RLAY 10
- Target Price
- MD $15.36
- RLAY $20.11
- AVG Volume (30 Days)
- MD 644.8K
- RLAY 2.6M
- Earning Date
- MD 11-01-2024
- RLAY 11-06-2024
- Dividend Yield
- MD N/A
- RLAY N/A
- EPS Growth
- MD N/A
- RLAY N/A
- EPS
- MD N/A
- RLAY N/A
- Revenue
- MD $2,006,998,000.00
- RLAY $10,006,000.00
- Revenue This Year
- MD $3.13
- RLAY N/A
- Revenue Next Year
- MD N/A
- RLAY N/A
- P/E Ratio
- MD N/A
- RLAY N/A
- Revenue Growth
- MD N/A
- RLAY N/A
- 52 Week Low
- MD $6.62
- RLAY $4.25
- 52 Week High
- MD $16.41
- RLAY $12.14
- Technical
- Relative Strength Index (RSI)
- MD 46.08
- RLAY 39.07
- Support Level
- MD $13.90
- RLAY $4.41
- Resistance Level
- MD $14.70
- RLAY $5.03
- Average True Range (ATR)
- MD 0.44
- RLAY 0.31
- MACD
- MD -0.12
- RLAY 0.05
- Stochastic Oscillator
- MD 21.67
- RLAY 20.65
About MD Pediatrix Medical Group Inc.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment and generates majority of the revenue through neonatology and other pediatric subspecialties.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).